Goldline Pharmaceutical Limited
Bookbuilding IPO · BSE
- Price band
- ₹41 - ₹43
- Lot size
- 3,000 shares
- Issue amount
- ₹11.61 cr
- Total subscription
- 840.81×
- Opens
- 12 May 2026
- Closes
- 14 May 2026
- Allotment
- 15 May 2026
- Listing
- 19 May 2026
Offer at a glance
Issue overview
- Issue size
- 27,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,23,000
- Fresh issue
- ₹11.61 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,29,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 69,00,000
- Shares after issue
- 96,00,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 6,000 | ₹2,58,000 |
| sHNI | 3 | 9,000 | ₹3,87,000 |
| bHNI | 8 | 24,000 | ₹10,32,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 14 May 2026
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 85 |
| NIB | 0 | 33,760 |
| RETAIL | 150 | 1,32,173 |
| EMPLOYEES | 0 | 0 |
| HNIs(10L +) | 29 | 20,429 |
| HNIs (2-10L) | 14 | 13,331 |
| Shareholder | 0 | 0 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 2.32 | 418.46 |
| FIIs | 0 | 109.38 |
| Others | 0 | 309.05 |
| RETAIL | 3.87 | 3,410.06 |
| HNIs 2+ | 0.56 | 556.67 |
| HNIs 10+ | 1.12 | 2,231.16 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| EPS | 3.22 | 4.1 | 3.01 |
| ROE | 21.02 | 35.83 | 31.31 |
| ROCE | 0 | 0 | 0 |
| RONW | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 10.47 | 0 |
| POST IPO(PE) | 14.56 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Goldline Pharmaceutical Limited | 10.47 | 0 | 10 | 12.38 | 27.37 | 4.1 |
| Mono Pharmacare Limited | 7.57 | 0 | 10 | 17.66 | 9.9 | 1.75 |
| Chandra Bhagat Pharma Limited | 28.94 | 0 | 10 | 39.72 | 2.86 | 1.14 |
Company information
Company profile
Goldline Pharmaceuticals markets pharmaceutical products under the “Goldline” brand, offering a wide range of medicines across five divisions—Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These products cater to various medical specialties including physicians, cardiologists, pediatricians, orthopedics, neurologists, critical care experts, and cancer supportive care. Instead of manufacturing medicines directly, the company works with third-party manufacturers who produce products based on its research and specifications while ensuring quality and regulatory compliance. Goldline sells its products through a network of distributors, retailers, and wholesalers, and also supports hospitals and healthcare providers with procurement and supply services. The company currently partners with 15 manufacturers and 7 distributors, with operations spread across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Strengths
- Asset-Light & Scalable Business Model: Outsourced manufacturing approach reduces capital requirements and supports expansion.
- Diversified Pharmaceutical Portfolio: Wide range of products across multiple therapeutic segments reduces dependency on one category.
- Strong Distribution & Supplier Network: Established relationships with manufacturers and distributors ensure smooth operations.
Risk factors
- Dependence on Third-Party Manufacturers: Reliance on external manufacturers may impact quality control and supply continuity.
- Regulatory Compliance Risks: Pharmaceutical industry is highly regulated and subject to strict approvals and standards.
- Limited Geographic Presence: Operations concentrated in selected Indian states may restrict nationwide growth.
Promoters
Amol Laxmikant Mujumdar
Swapan Premprakash Khandelwal
Registrar & documents
Lead manager
Cumulative Capital Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur, Maharashtra, 440015
+91 712 2786666
[email protected]Company website ↗Understanding GLPL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.